Select Location
What is your delivery location?
We need your delivery location to continue browsing
Select Location
We need your delivery location to continue browsing
Prescription Required
Natco
28 Capsules in Bottle
Sunitinib
Keep in cold place
Delivering To:
Overview
Sutinat 12.5mg capsule belongs to the category of anticancer medicines. These medicines are primarily used to treat kidney cancer, gastrointestinal stromal tumors, and pancreatic cancer, called pancreatic neuroendocrine tumors (PNET). The growth of cancer cells is uncontrollable and abnormal in the human body. It is difficult to diagnose cancer in its early stages. When diagnosed in advanced stages, only the symptoms of the disease can be reduced. Sutinat capsule is not recommended for children under age 18.
Kidney Cancer, Gastrointestinal stromal tumors
Kidney cancer
Gastrointestinal stromal tumour
The human body shows undesired symptoms after taking the Sutinat 12.5mg capsule. Usually, they disappear with time as the body adjusts to the medicine. These side effects don't need special medical attention. It is advised to consult your doctor if these symptoms become unmanageable.
Some of the common side effects of Sutinat capsule are mentioned below:
Fever
Fatigue
Diarrhea
Hair loss
Headache
Dehydration, Constipation, Nose bleeding
Abdominal Pain
High blood pressure
Low blood cell count
Nausea and vomiting
Weakness & Dizziness
Skin rashes, itching, and irritation. Severe side effects:
Liver failure
Hemorrhage
Heart failure
Kidney injury
Low blood sugar
Low thyroid level
Increase the level of liver enzymes
Sutinat 12.5mg capsule is a prescription-based anticancer drug that should be administered orally. It is advised to take this capsule after consulting your healthcare expert.
Sutinat 12.5mg capsule is an anticancer medicine that belongs to the drug class of tyrosine kinase inhibitor. This medication inhibits the tyrosine kinase, a surface protein that causes cancer cells to proliferate quickly. Additionally, it prevents the development of the blood vessels that provide tumor cells with oxygen. This capsule inhibits the development and spread of cancer cells in this way.
Alcohol
consult your doctor
The interaction of alcohol with this drug is still unknown. It is advisable not to consume alcohol while taking Sutinat 12.5mg capsule. It is advised to consult your doctor for further information.
Pregnancy
consult your doctor
Sutinat 12.5mg capsule may be considered unsafe during pregnancy. Please consult your doctor in such condition.
Breast Feeding
consult your doctor
Sutinat 12.5mg capsule is probably not safe if you're breastfeeding. Kindly consult your doctor.
Driving
unsafe
It is advisable not to drive or operate heavy machinery as you may feel dizzy after taking Sutinat 12.5mg capsule.
Kidney
safe if prescribed
Share your medical history with your healthcare expert in case of kidney disease before taking Sutinat 12.5mg capsule.
Liver
safe if prescribed
Inform your doctor before starting Sutinat 12.5mg capsule if you have liver disease to avoid any serious side effects.
It is advised not to miss any scheduled dosage of Sutinat 12.5mg capsule. In case you miss a dose, consult your doctor immediately.
Don't overdose to compensate for the missed one. Contact your doctor or any healthcare provider and seek medical attention immediately in such cases.
It is advised to use effective birth control ways and avoid pregnancy during the treatment with Sutinat 12.5mg capsule.
A person should avoid smoking while undergoing treatment with Sutinat 12.5mg capsule. Smoking may reduce the effectiveness of medicine.
Skin becomes extremely sensitive after taking Sutinat capsule. It is advised to cover your skin exposed to direct sun rays and use high SPF sunscreen before going out.
Swelling of hands, lips, and weight gain are some of the side effects observed after taking Sutinat 12.5mg capsule. To reduce them, the doctor may suggest some medication.
It is advised to avoid taking analgesics/ antacids (medicines used to neutralize the stomach acid) while taking Sutinat capsule, as it may reduce the effectiveness of the medicine.
Keep your body hydrated as Diarrhea is one of the common side effects experienced after taking Sutinat 12.5mg capsule. Consult your doctor if it doesn't stop or if blood appears in your stools.
Monitor your blood sugar & pressure, Kidney & Liver function (KFT & LFT), Heart function, cholesterol level and bone mineral density (BMD) at proper intervals after taking Sutinat.
In case you notice symptoms like blurred vision, difficulty breathing, cough & fever, and diarrhea while taking Sutinat 12.5mg capsule, consult your doctor immediately before these symptoms become severe.
If you experience any kind of symptoms after taking Sutinat 12.5mg capsule, like unexplained bruising or bleeding, sore throat, mouth ulcers, high temperature (fever), or other signs of infection, it is important to Inform your doctor as soon as possible.
Yes, It is advised to use contraceptive pills or birth control pills for at least 3 to 6 months even after completing the treatment with Sutinat 12.5mg capsule. It is compulsory because this drug can pass through the mother's blood or the father's semen and can harm the unborn baby.
Yes, Sutinat 12.5mg capsule is safe for a person who has a thyroid disorder. Your healthcare provider will monitor thyroid function at regular intervals.
Yes, taking the Sutinat capsule may cause some skin discoloration. In severe cases, it results in hand-foot syndrome, which is indicated by pain, redness, and swelling in hands and feet.
Taking the Sutinat capsule may result in a decrease in the level of white blood cell, platelet, and red blood cell counts.
Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database. (2024). Journal of Hepatology and Oncology. Efficacy and safety of sorafenib versus sunitinib as first-line treatment in metastatic renal cell carcinoma: Largest single-center retrospective analysis. (2023). Oncotarget / PMC open-access database.
Model‑based dose individualization of sunitinib in gastrointestinal stromal tumors. (2025). Clinical Cancer Research. https://aacrjournals.org/clincancerres/article-abstract/26/17/4590/82846/Model-based-Dose-Individualization-of-Sunitinib-in?redirectedFrom=fulltext&utm.
Population pharmacokinetics of sunitinib and its active metabolite SU012662 in pediatric patients with gastrointestinal stromal tumors or other solid tumors. (2025). Pediatric Oncology Group / Clinical study. https://pmc.ncbi.nlm.nih.gov/articles/PMC8093178/?utm
Randomized phase II trial evaluating the addition of low-dose, short-course sunitinib (12.5 mg) to docetaxel in advanced solid tumors. (2020). British Journal of Cancer.
